Vaidam Health Acquires CancerRounds

IMT News Desk
IMT News Desk
· 3 min read
Vaidam Health has acquired oncology-focused platform CancerRounds to strengthen its cancer care navigation

Vaidam Health has announced the acquisition of CancerRounds, an oncology-focused healthcare platform that supports cancer patients in connecting with doctors, hospitals and treatment options.

Vaidam Health aims to further strengthen its oncology-focused patient navigation capabilities and enhance support for patients seeking comprehensive and coordinated cancer care solutions across borders.

CancerRounds is a platform for assisting both domestic and international cancer patients by having tie-ups with leading cancer centers and doctors. They have helped more than 5,000+ patients, facilitated connections with over 500+ oncologists, and worked with over 200 hospitals globally. Achieving high patient satisfaction, CancerRounds has established itself as a pioneer in assisting patients in their journey with difficult cancer diagnoses

For international patients, cancer care can be particularly difficult to navigate. Treatment often involves multiple medical opinions, clarity on available therapies, quick decision-making, access to the right specialist, financial planning, medical documentation, visas, travel and accommodation. These challenges become more urgent in advanced-stage cases, where delays or fragmented information can affect the overall treatment journey.

“Oncology has consistently been one of our largest medical travel verticals. Cancer patients and their families often need a higher level of guidance because treatment decisions are time-sensitive, specialized and deeply personal. CancerRounds has built focused experience in oncology care navigation, and this acquisition allows us to bring that capability into our existing international patient services,” said Pankaj Chandna, Co-founder of Vaidam Health.

The acquisition will enable the integration of CancerRounds’ oncology care navigation experience with Vaidam Health’s international patient services. The combined work will focus on doctor discovery, treatment opinion coordination, hospital shortlisting, documentation assistance, travel coordination and post-treatment follow-up for patients seeking cancer treatment outside their home country.

“Every cancer journey is deeply personal and patients need access to the right expertise at the right time. CancerRounds was built to help patients and families navigate this difficult journey with greater clarity. As part of Vaidam Health, CancerRounds will now be able to support a larger international patient community while continuing its focus on cancer care guidance,” said Sumit Wadhwa, Co-founder of CancerRounds.

The acquisition also reflects a broader shift within medical value travel, where patients are no longer looking only for access to hospitals, but for specialty-led guidance that can help them understand treatment options, compare care pathways and manage the practical challenges of seeking treatment across borders.

Last year, Vaidam Health acquired MediJourney, a healthcare facilitation technology platform incubated by Ferns N Petals, to strengthen its digital infrastructure, AI-based communication processes and multilingual patient onboarding capabilities.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk